UTHR
UNITED THERAPEUTICS CorpCompany Information
- Company Name
- UNITED THERAPEUTICS Corp
- CIK
- CIK0001082554
- Category
- Large accelerated filer
- Ticker: Exchange
- UTHR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- UTHR
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-26
- Last sale
- 2026-09-29
- Shares purchased (TTM)
- 1,500
- Shares sold (TTM)
- 2,602,263
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 39,763,377
- Shares outstanding
- 42,600,000
- Ownership
- 93.34%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -0.68%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1,803 | 1,280 | 1,557 | 1,340 | 1,593 | 1,900 | 1,697 | 1,554 | 1,356 | 1,252 | 1,208 | 1,108 | ||||||
| Marketable Securities Current | 859 | 874 | 1,363 | 1,428 | 1,456 | 1,421 | 1,570 | 1,773 | 1,616 | 1,456 | 1,786 | 1,768 | ||||||
| Accounts Receivable Net Current | 310 | 312 | 350 | 298 | 379 | 322 | 279 | 342 | 291 | 307 | 279 | 259 | ||||||
| Inventory Net | 194 | 178 | 183 | 177 | 169 | 165 | 158 | 147 | 137 | 120 | 112 | 104 | ||||||
| Other Assets Current | 317 | 228 | 249 | 252 | 230 | 131 | 170 | 185 | 221 | 113 | 166 | 221 | ||||||
| Assets Current | 3,484 | 2,872 | 3,703 | 3,494 | 3,827 | 3,940 | 3,874 | 4,000 | 3,620 | 3,249 | 3,551 | 3,459 | ||||||
| Marketable Securities Noncurrent | 1,141 | 1,317 | 1,777 | 1,567 | 1,918 | 1,711 | 1,475 | 1,279 | 1,330 | 1,492 | 1,910 | 2,061 | ||||||
| Intangible Assets Net Including Goodwill | 114 | 116 | 117 | 117 | 112 | 112 | 112 | 112 | 115 | 115 | 114 | 44 | ||||||
| Property Plant And Equipment Net | 1,930 | 1,841 | 1,730 | 1,556 | 1,362 | 1,303 | 1,222 | 1,157 | 1,095 | 1,074 | 1,045 | 992 | ||||||
| Deferred Income Tax Assets Net | 312 | 335 | 358 | 355 | 456 | 457 | 458 | 391 | 396 | 396 | 395 | 326 | ||||||
| Other Assets Noncurrent | 240 | 233 | 197 | 263 | 233 | 222 | 222 | 184 | 168 | 169 | 152 | 142 | ||||||
| Assets | 7,220 | 6,714 | 7,880 | 7,351 | 7,908 | 7,744 | 7,364 | 7,123 | 6,723 | 6,495 | 7,167 | 7,024 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 498 | 498 | 488 | 468 | 432 | 367 | 345 | 364 | 325 | 305 | 298 | 333 | ||||||
| Lines Of Credit Current | - | - | 0 | 0 | 0 | 200 | 300 | 400 | 400 | 400 | 400 | 300 | ||||||
| Other Liabilities Current | 110 | 101 | 73 | 78 | 95 | 155 | 94 | 80 | 78 | 126 | 71 | 70 | ||||||
| Liabilities Current | 608 | 599 | 561 | 546 | 527 | 722 | 738 | 873 | 832 | 861 | 804 | 744 | ||||||
| Other Liabilities Noncurrent | 212 | 214 | 223 | 215 | 207 | 215 | 182 | 149 | 94 | 97 | 78 | 67 | ||||||
| Long Term Line Of Credit | - | - | - | - | - | - | 0 | 0 | 100 | 200 | 300 | 500 | ||||||
| Liabilities | 820 | 813 | 784 | 761 | 734 | 937 | 920 | 1,022 | 1,026 | 1,157 | 1,182 | 1,312 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital Common Stock | 2,896 | 2,520 | 2,798 | 2,659 | 2,793 | 2,738 | 2,699 | 2,647 | 2,543 | 2,405 | 2,549 | 2,524 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -16 | -10 | 1 | 0 | 0 | -1 | -3 | 7 | -15 | -16 | -13 | -44 | ||||||
| Treasury Stock Common Value | -5,645 | -5,442 | -4,260 | -4,262 | -3,475 | -3,475 | -3,475 | -3,475 | -3,444 | -3,386 | -2,579 | -2,579 | ||||||
| Retained Earnings Accumulated Deficit | 9,165 | 8,832 | 8,557 | 8,193 | 7,854 | 7,544 | 7,222 | 6,921 | 6,612 | 6,334 | 6,027 | 5,810 | ||||||
| Stockholders Equity | 6,400 | 5,901 | 7,096 | 6,590 | 7,174 | 6,807 | 6,444 | 6,101 | 5,697 | 5,338 | 5,985 | 5,712 | ||||||
| Liabilities And Stockholders Equity | 7,220 | 6,714 | 7,880 | 7,351 | 7,908 | 7,744 | 7,364 | 7,123 | 6,723 | 6,495 | 7,167 | 7,024 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 245 | 245 | 245 | 245 | 245 | 245 | 245 | 245 | 245 | 245 | 245 | 245 | ||||||
| Common Stock Shares Issued | 78 | 77 | 76 | 76 | 75 | 75 | 75 | 75 | 74 | 74 | 74 | 74 | ||||||
| Shares Outstanding | 43 | 42 | 44 | 43 | 45 | 45 | 45 | 45 | 44 | 44 | 47 | 47 | ||||||
| Treasury Stock Common Shares | 35 | 35 | 33 | 33 | 30 | 30 | 30 | 30 | 30 | 30 | 27 | 27 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialUNITED THERAPEUTICS Corp (UTHR) — SEC Financial Statements & Analysis
UNITED THERAPEUTICS Corp (UTHR) is a pharmaceutical preparations company, incorporated in DE. UNITED THERAPEUTICS Corp trades on Nasdaq as: UTHR. UNITED THERAPEUTICS Corp (UTHR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, UNITED THERAPEUTICS Corp carries a market cap of $23.08B, a P/E ratio of 17.61x, a P/B ratio of 3.61x, a P/S ratio of 7.32x, an enterprise value of $21.28B, and an EV/EBITDA multiple of 14.25x. On profitability, it posts a gross margin of 86.14%, an operating margin of 44.44%, a net margin of 41.56%, a Return on Equity (ROE) of 19.32%, a Return on Assets (ROA) of 17.33%, and a Return on Invested Capital (ROIC) of 22.68%. Per share, it reports EPS of $30.77, diluted EPS of $28.62, free cash flow per share of $25.66, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 2.49% year-over-year, net income growth of 5.54% year-over-year, and EPS growth of 11.73% year-over-year. On the balance sheet, it maintains a current ratio of 5.73x, a quick ratio of 5.41x, working capital of $2.88B, a debt-to-equity ratio of 0.13x, a debt ratio of 0.11, an interest coverage ratio of 116.82x, free cash flow of $1.09B (TTM), and net debt of $-1.80B. Figures sourced from SEC EDGAR.
- Market Cap
- $23.08B
- P/E TTM
- 17.61x
- EPS TTM
- $30.77
- P/B TTM
- 3.61x
- ROE TTM
- 19.32%
- ROA TTM
- 17.33%
- Debt To Equity
- 0.13x
- Free Cash Flow TTM
- $1.09B
- Net Revenue TTM Growth 1Y
- 2.49%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is UNITED THERAPEUTICS Corp in?
UNITED THERAPEUTICS Corp (UTHR) operates in the Pharmaceutical Preparations industry.
What exchange does UTHR trade on?
UNITED THERAPEUTICS Corp (UTHR) trades on the Nasdaq.
Where is UNITED THERAPEUTICS Corp incorporated?
UNITED THERAPEUTICS Corp is incorporated in DE.
When was UNITED THERAPEUTICS Corp (UTHR)'s most recent SEC filing?
UNITED THERAPEUTICS Corp (UTHR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is UTHR's market cap?
UNITED THERAPEUTICS Corp (UTHR) has a market capitalization of $23.08B as of 2026-06-30.
What is UTHR's P/E ratio?
UNITED THERAPEUTICS Corp (UTHR)'s trailing twelve month P/E ratio is 17.61x as of 2026-06-30.
What is UTHR's EPS (earnings per share)?
UNITED THERAPEUTICS Corp (UTHR)'s trailing twelve month EPS is $30.77 as of 2026-06-30.
What is UTHR's ROE (return on equity)?
UNITED THERAPEUTICS Corp (UTHR)'s trailing twelve month Return on Equity (ROE) is 19.32% as of 2026-06-30.
What is UTHR's ROA (return on assets)?
UNITED THERAPEUTICS Corp (UTHR)'s trailing twelve month Return on Assets (ROA) is 17.33% as of 2026-06-30.
What is UTHR's ROIC (return on invested capital)?
UNITED THERAPEUTICS Corp (UTHR)'s trailing twelve month Return on Invested Capital (ROIC) is 22.68% as of 2026-06-30.
What is UTHR's EV/EBITDA?
UNITED THERAPEUTICS Corp (UTHR)'s trailing twelve month EV/EBITDA is 14.25x as of 2026-06-30.